Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Eder João Lenardão, Raquel G. Jacob, Katiúcia D. Mesquita, Renata G. Lara, Rodrigo Webber, Débora Martins Martinez, Lucielli Savegnago, Samuel R. Mendes, Diego Alves & Gelson Perin. (2013) Glycerol as a promoting and recyclable medium for catalyst-free synthesis of linear thioethers: new antioxidants from eugenol. Green Chemistry Letters and Reviews 6:4, pages 269-276.
Read now
Read now
Hironobu Sasano, Yasuhiro Miki, Tsuyoshi Fukuda, Shuji Nagasaki, Taisuke Nakata & Takashi Suzuki. (2007) New development in intracrinology of breast carcinoma: therapeutic horizons after aromatase inhibitors. Expert Review of Endocrinology & Metabolism 2:3, pages 367-374.
Read now
Read now
Articles from other publishers (28)
Matías I. Quindt, Stefano Protti, Daniele Merli & Sergio M. Bonesi. (2023) Photoinduced One‐Electron Oxidation of Estrone Derivatives: A Combined Steady‐State and Time‐Resolved Spectroscopy Investigation. ChemPhotoChem 7:10.
Crossref
Crossref
Matías I. Quindt, Gabriel F. Gola, Cristian R. Rodriguez, Javier A. Ramirez & Sergio M. Bonesi. (2022) Product selectivity in the photoreaction of aryl sulfonates and mesylate of estrone derivatives in sustainable and micellar media: a steady-state investigation. New Journal of Chemistry 46:32, pages 15504-15520.
Crossref
Crossref
Matías I. Quindt, Gabriel F. Gola, Javier A. Ramirez & Sergio M. Bonesi. (2020) Photochemical Behavior of Some Estrone Aryl and Methyl Sulfonates in Solution: Preparative and Mechanistic Studies. Photochemistry and Photobiology 97:1, pages 8-21.
Crossref
Crossref
René Maltais, Martin Perreault, Jenny Roy & Donald Poirier. (2020) Minor chemical modifications of the aminosteroid derivative RM-581 lead to major impact on its anticancer activity, metabolic stability and aqueous solubility. European Journal of Medicinal Chemistry 188, pages 111990.
Crossref
Crossref
René Maltais & Donald Poirier. (2019) Development of a Gram-Scale Synthesis of PBRM, an Irreversible Inhibitor of 17β-Hydroxysteroid Dehydrogenase Type 1. Organic Process Research & Development 23:11, pages 2323-2335.
Crossref
Crossref
Matías I. Quindt, Gabriel F. Gola, Javier A. Ramirez & Sergio M. Bonesi. (2019) Photo-Fries Rearrangement of Some 3-Acylestrones in Homogeneous Media: Preparative and Mechanistic Studies. The Journal of Organic Chemistry 84:11, pages 7051-7065.
Crossref
Crossref
Mohamed Salah, Ahmed S. Abdelsamie & Martin Frotscher. (2019) Inhibitors of 17β-hydroxysteroid dehydrogenase type 1, 2 and 14: Structures, biological activities and future challenges. Molecular and Cellular Endocrinology 489, pages 66-81.
Crossref
Crossref
Jovana Trifunović, Vladan Borčić, Saša Vukmirović & Momir Mikov. (2017) Structural insights into anticancer activity of D-ring modified estrone derivatives using their lipophilicity in estimation of SAR and molecular docking studies. Drug Testing and Analysis 9:10, pages 1542-1548.
Crossref
Crossref
Diana Ayan, René Maltais, Jenny Roy & Donald Poirier. (2012) A New Nonestrogenic Steroidal Inhibitor of 17β-Hydroxysteroid Dehydrogenase Type I Blocks the Estrogen-Dependent Breast Cancer Tumor Growth Induced by Estrone. Molecular Cancer Therapeutics 11:10, pages 2096-2104.
Crossref
Crossref
Carina Neto, Maria Cristina Oliveira, Lurdes Gano, Fernanda Marques, Takumi Yasuda, Thies Thiemann, Torsten Kniess & Isabel Santos. (2012) Novel 7α-alkoxy-17α-(4′-halophenylethynyl)estradiols as potential SPECT/PET imaging agents for estrogen receptor expressing tumours: Synthesis and binding affinity evaluation. Steroids 77:11, pages 1123-1132.
Crossref
Crossref
Donald Poirier. (2011) Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: Key tools for studying and treating estrogen-dependent diseases. The Journal of Steroid Biochemistry and Molecular Biology 125:1-2, pages 83-94.
Crossref
Crossref
Gabriele Möller, Bettina Husen, Dorota Kowalik, Leena Hirvelä, Dariusz Plewczynski, Leszek Rychlewski, Josef Messinger, Hubert Thole & Jerzy Adamski. (2010) Species Used for Drug Testing Reveal Different Inhibition Susceptibility for 17beta-Hydroxysteroid Dehydrogenase Type 1. PLoS ONE 5:6, pages e10969.
Crossref
Crossref
Juliette A. Aka, Mausumi Mazumdar, Chang-Qing Chen, Donald Poirier & Sheng-Xiang Lin. (2010) 17β-Hydroxysteroid Dehydrogenase Type 1 Stimulates Breast Cancer by Dihydrotestosterone Inactivation in Addition to Estradiol Production. Molecular Endocrinology 24:4, pages 832-845.
Crossref
Crossref
Gabriele Möller, Dominga Deluca, Christian Gege, Andrea Rosinus, Dorota Kowalik, Olaf Peters, Peter Droescher, Walter Elger, Jerzy Adamski & Alexander Hillisch. (2009) Structure-based design, synthesis and in vitro characterization of potent 17β-hydroxysteroid dehydrogenase type 1 inhibitors based on 2-substitutions of estrone and D-homo-estrone. Bioorganic & Medicinal Chemistry Letters 19:23, pages 6740-6744.
Crossref
Crossref
Michelle-Audrey Fournier & Donald Poirier. (2009) Estrogen formation in endometrial and cervix cancer cell lines: Involvement of aromatase, steroid sulfatase and 17β-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12). Molecular and Cellular Endocrinology 301:1-2, pages 142-145.
Crossref
Crossref
Yannick Laplante, Claudine Rancourt & Donald Poirier. (2009) Relative involvement of three 17β-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors. Molecular and Cellular Endocrinology 301:1-2, pages 146-153.
Crossref
Crossref
Marc Meier, Gabriele Möller & Jerzy Adamski. (2009) Perspectives in Understanding the Role of Human 17β-Hydroxysteroid Dehydrogenases in Health and Disease. Annals of the New York Academy of Sciences 1155:1, pages 15-24.
Crossref
Crossref
Patrick Bydal, Van Luu-The, Fernand Labrie & Donald Poirier. (2009) Steroidal lactones as inhibitors of 17β-hydroxysteroid dehydrogenase type 5: Chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities. European Journal of Medicinal Chemistry 44:2, pages 632-644.
Crossref
Crossref
D. Fournier, D. Poirier, M. Mazumdar & S.-X. Lin. (2008) Design and synthesis of bisubstrate inhibitors of type 1 17β-hydroxysteroid dehydrogenase: Overview and perspectives. European Journal of Medicinal Chemistry 43:11, pages 2298-2306.
Crossref
Crossref
Sandrine Marchais-Oberwinkler, Patricia Kruchten, Martin Frotscher, Erika Ziegler, Alexander Neugebauer, Umadevi Bhoga, Emmanuel Bey, Ursula Müller-Vieira, Josef Messinger, Hubert Thole & Rolf W. Hartmann. (2008) Substituted 6-Phenyl-2-naphthols. Potent and Selective Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1): Design, Synthesis, Biological Evaluation, and Pharmacokinetics. Journal of Medicinal Chemistry 51:15, pages 4685-4698.
Crossref
Crossref
Emmanuel Bey, Sandrine Marchais-Oberwinkler, Patricia Kruchten, Martin Frotscher, Ruth Werth, Alexander Oster, Oztekin Algül, Alexander Neugebauer & Rolf W. Hartmann. (2008) Design, synthesis and biological evaluation of bis(hydroxyphenyl) azoles as potent and selective non-steroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) for the treatment of estrogen-dependent diseases. Bioorganic & Medicinal Chemistry 16:12, pages 6423-6435.
Crossref
Crossref
GÉRARD CHETRITE. 2008. Breast Cancer. Breast Cancer
11
48
.
Takumi Yasuda, Yuji Shima, Keiko Ideta, Cristina das Neves Oliveira & Thies Thiemann. (2008) 7α-Alkoxyestra-1,3,5(10)-Trienes. Journal of Chemical Research 2008:1, pages 32-37.
Crossref
Crossref
Christine Cadot, Yannick Laplante, Fatima Kamal, Van Luu-The & Donald Poirier. (2007) C6-(N,N-butyl-methyl-heptanamide) derivatives of estrone and estradiol as inhibitors of type 1 17β-hydroxysteroid dehydrogenase: Chemical synthesis and biological evaluation. Bioorganic & Medicinal Chemistry 15:2, pages 714-726.
Crossref
Crossref
Hironobu Sasano, Takashi Suzuki, Taisuke Nakata & Takuya Moriya. (2006) New development in intracrinology of breast carcinoma. Breast Cancer 13:2, pages 129-136.
Crossref
Crossref
B. Husen, K. Huhtinen, M. Poutanen, L. Kangas, J. Messinger & H. Thole. (2006) Evaluation of inhibitors for 17β-hydroxysteroid dehydrogenase type 1 in vivo in immunodeficient mice inoculated with MCF-7 cells stably expressing the recombinant human enzyme. Molecular and Cellular Endocrinology 248:1-2, pages 109-113.
Crossref
Crossref
Béatrice Tchédam Ngatcha, Yannick Laplante, Fernand Labrie, Van Luu-The & Donald Poirier. (2006) 3β-Alkyl-androsterones as inhibitors of type 3 17β-hydroxysteroid dehydrogenase: Inhibitory potency in intact cells, selectivity towards isoforms 1, 2, 5 and 7, binding affinity for steroid receptors, and proliferative/antiproliferative activities on AR+ and ER+ cell lines. Molecular and Cellular Endocrinology 248:1-2, pages 225-232.
Crossref
Crossref
Donald Poirier, Roch P. Boivin, Martin R. Tremblay, Marie Bérubé,, Wei Qiu & Sheng-Xiang Lin. (2005) Estradiol−Adenosine Hybrid Compounds Designed to Inhibit Type 1 17β-Hydroxysteroid Dehydrogenase. Journal of Medicinal Chemistry 48:26, pages 8134-8147.
Crossref
Crossref